Edwards Lifesciences Revenues USD Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 141.34  4.04  2.94%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Revenues USD of Edwards Lifesciences Corporation with missing and latest data points interpolated. Revenues in USD, converted by [FXUSD].
Revenues USD  10 Years Trend  
Slightly volatile
 Revenues USD 

Edwards Lifesciences Revenues USD Over Time

2016-12-31  2,963,700,000 
2017-12-31  2,963,700,000 
2018-12-31  2,872,315,789 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  1,925,331,984
Geometric Mean  1,772,410,435
Coefficient Of Variation  39.37
Mean Deviation  632,280,598
Median  1,899,600,000
Standard Deviation  757,927,739
Range  2,271,600,000
R Value  0.99
R Squared  0.98
Significance  0
Slope  192,219,202

Currently Trending

Sold over 70 shares of
2 days ago ago
Traded for 37.94
Purchased over 40 shares of
2 days ago ago
Traded for 61.5945
Sold over 200 shares of
2 days ago ago
Traded for 11.15